Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Name | BRAF V600E SRC over exp |
| Gene Variant Detail | |
| Relevant Treatment Approaches |
| Molecular Profile | Indication/Tumor Type | Response Type | Relevant Treatment Approaches | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|---|
| BRAF V600E SRC over exp | colorectal cancer | resistant | Vemurafenib | Preclinical - Cell culture | Actionable | In a preclinical study, Src-overexpressing colorectal cancer cell lines harboring BRAF V600E were resistant to Zelboraf (vemurafenib) in culture (PMID: 40481178). | 40481178 | |
| BRAF V600E SRC over exp | colorectal cancer | resistant | Encorafenib | Preclinical - Cell culture | Actionable | In a preclinical study, Src-overexpressing colorectal cancer cell lines harboring BRAF V600E were resistant to Braftovi (encorafenib) in culture (PMID: 40481178). | 40481178 |